About: Impact of COVID-19 Pandemic on Dermatologists and Dermatology Practice

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Impact of COVID-19 Pandemic on Dermatologists and Dermatology Practice Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Impact of COVID-19 Pandemic on Dermatologists and Dermatology Practice
Creator	Aslam, Aaqib Bhat, Yasmeen Dogra, Sunil Hassan, Iffat
topic	covid:970c2ca6fce40b0ab3484c5a196fde844ef8f7a7#this
Source	Medline; PMC
abstract	The COVID-19 pandemic has directly or indirectly affected every human being on this planet. It's impact on the healthcare system has been devastating. The medical fraternity across the world, including India, is facing unprecedented challenges in striving to cope up with this catastrophic outbreak. Like all other specialties, dermatology practice has been profoundly affected by this pandemic. Measures have been taken by dermatologists to control the transmission of the virus, whereas providing health care to patients in the constrained environment. Preventive measures such as social distancing and hand hygienic practices along with patient education is being prioritized. Dermatological conferences and events scheduled across the globe in the first half of year 2020 have been either cancelled or postponed to discourage gatherings. Rationalization of resources and practice of teledermatology are being encouraged in current scenario. Non-urgent visits of the patients are being discouraged and elective dermatology procedures are being postponed. Many national and international dermatology societies have recently proposed recommendations and advisories on usage of biologicals and immunomodulators in present context of COVID-19 pandemic. Urticarial, erythematous, varicelliform, purpuric and livedoid rash as well as aggravation of preexisting dermatological diseases like rosacea, eczema, atopic dermatitis, and neurodermatitis rash have been reported in Covid-19 patients. Self medications and poor compliance of dermatology patients in addition to lack of proper treatment protocols and monitoring are a serious concern in the present scenario. Strategies for future course of action, including the dermatology specific guidelines need to be framed. This issue includes a special symposium on dermatology and COVID-19 having recommendations from special interest groups (SIGs) of Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) Academy on leprosy, dermatosurgery, lasers and dermoscopy.
has issue date	2020-05-10(xsd:dateTime)
bibo:doi	10.4103/idoj.idoj_180_20
bibo:pmid	32695687
has license	cc-by-nc-sa
sha1sum (hex)	970c2ca6fce40b0ab3484c5a196fde844ef8f7a7
schema:url	https://doi.org/10.4103/idoj.idoj_180_20
resource representing a document's title	Impact of COVID-19 Pandemic on Dermatologists and Dermatology Practice
has PubMed Central identifier	PMC7367587
has PubMed identifier	32695687
schema:publication	Indian Dermatol Online J
resource representing a document's body	covid:970c2ca6fce40b0ab3484c5a196fde844ef8f7a7#body_text
is http://vocab.deri.ie/void#inDataset of	https://covidontheweb.inria.fr:4443/about/id/http/ns.inria.fr/covid19/970c2ca6fce40b0ab3484c5a196fde844ef8f7a7
is schema:about of	named entity 'pandemic' named entity 'neurodermatitis' named entity 'diseases' named entity 'usage' named entity 'biologicals' named entity 'pandemic' named entity 'Self' named entity 'dermatitis' named entity 'patients' named entity 'leprosy' named entity 'Preventive' named entity 'framed' named entity 'dermatology' named entity 'hygienic practices' named entity 'COVID-19 pandemic' named entity 'virus' named entity 'rosacea' named entity 'purpuric' named entity 'COVID-19 pandemic' named entity 'dermatology' named entity 'rash' named entity 'dermatological diseases' named entity 'dermatology' named entity 'erythematous' named entity 'Dermatologists' named entity 'Dermatology' named entity 'visits' named entity 'rash' named entity 'leflunomide' named entity 'hygienic practices' named entity 'co-morbidities' named entity 'COVID-19 pandemic' named entity 'IL1' named entity 'public health' named entity 'rash' named entity 'vesicular' named entity 'teledermatology' named entity 'lockdown' named entity 'clinical practice' named entity 'dermatologists' named entity 'HCW' named entity 'British Association of Dermatologists' named entity 'dermatology' named entity 'disinfection' named entity 'virus' named entity 'tested positive' named entity 'COVID-19' named entity 'MDT' named entity 'quality of life' named entity 'high-risk' named entity 'infection' named entity 'immunosuppressive' named entity 'eczema' named entity 'dermatological' named entity 'Outpatient' named entity 'dermatologists' named entity 'blended learning' named entity 'rash' named entity 'dermatologic' named entity 'parasitic infections' named entity 'telemedicine' named entity 'surgical masks' named entity 'health systems' named entity 'COVID' named entity 'neurodermatitis' named entity 'higher risk' named entity 'mobile internet' named entity 'dengue' named entity 'COVID' named entity 'developing countries' named entity 'rituximab' named entity 'biologicals' named entity 'scientific research' named entity 'resources and manpower' named entity 'dermatology' named entity 'apremilast'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software